Relevant bibliographies by topics / Tobacco Use Disorder

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Tobacco Use Disorder'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tobacco Use Disorder.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tobacco Use Disorder"

1

Leone, Frank T., and Sarah Evers-Casey. "Tobacco Use Disorder." Medical Clinics of North America 106, no. 1 (January 2022): 99–112. http://dx.doi.org/10.1016/j.mcna.2021.08.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

DiFranza, Joseph R., Chaya Bhuvaneswar, Denise Jolicoeur, Susanne E. Tanski, and Jonathan Winickoff. "Tobacco Use Disorder." Journal of Addiction Medicine 10, no. 3 (2016): 143–47. http://dx.doi.org/10.1097/adm.0000000000000181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schmidt, Lasse David, Elisa Wegmann, Anja Bischof, Lena Klein, Chang Zhou, Dmitri Rozgonjuk, Christopher Kannen, et al. "Implicit Cognitions, Use Expectancies and Gratification in Social-Networks-Use Disorder and Tobacco Use Disorder." SUCHT 68, no. 5 (October 1, 2022): 279–91. http://dx.doi.org/10.1024/0939-5911/a000782.

Full text
Abstract:
Abstract: Aims: The problematic use of social networks is discussed as a further specific type of Internet-use disorders. Our project aims to clarify whether social-networks-use disorder (SNUD) is marked by characteristics of addictive behaviors by tracking behavior and investigating the relevance of 1) implicit cognitions, 2) the experiences of gratification and compensation and 3) use expectancies in SNUD compared to tobacco-use disorder. Methodology: Four groups will be examined: individuals with 1) SNUD without tobacco use, 2) risky use patterns with regard to social networks without tobacco use, 3) tobacco use disorder and 4) healthy controls. All participants first complete a laboratory examination including the Implicit Association Test (IAT) and the Approach-Avoidance task (AAT). We will use smartphone-based data tracking for 14 days following laboratory testing to record smoking and social-networks-use patterns. During this period, we further measure use expectancies and the experience of gratification and compensation by means of a smartphone-based experience sampling method (ESM). Conclusions: This is the first study to examine relevant characteristics of addictive behaviors in individuals with SNUD compared to individuals with tobacco use, using a combination of experimental psychological methods and smartphone-based measurements. We expect that this investigative approach will contribute to a deeper understanding of the processes involved in SNUD.
APA, Harvard, Vancouver, ISO, and other styles
4

Zawertailo, Laurie, Sophia Attwells, Wayne K. deRuiter, Thao Lan Le, Danielle Dawson, and Peter Selby. "Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms." Nutrients 12, no. 12 (December 15, 2020): 3834. http://dx.doi.org/10.3390/nu12123834.

Full text
Abstract:
As food addiction is being more commonly recognized within the scientific community, parallels can be drawn between it and other addictive substance use disorders, including tobacco use disorder. Given that both unhealthy diets and smoking are leading risk factors for disability and death, a greater understanding of how food addiction and tobacco use disorder overlap with one another is necessary. This narrative review aimed to highlight literature that investigated prevalence, biology, psychology, and treatment options of food addiction and tobacco use disorder. Published studies up to August 2020 and written in English were included. Using a biopsychosocial lens, each disorder was assessed together and separately, as there is emerging evidence that the two disorders can develop concurrently or sequentially within individuals. Commonalities include but are not limited to the dopaminergic neurocircuitry, gut microbiota, childhood adversity, and attachment insecurity. In addition, the authors conducted a feasibility study with the purpose of examining the association between food addiction symptoms and tobacco use disorder among individuals seeking tobacco use disorder treatment. To inform future treatment approaches, more research is necessary to identify and understand the overlap between the two disorders.
APA, Harvard, Vancouver, ISO, and other styles
5

Thomson, Daniel, Michael Berk, Seetal Dodd, Marta Rapado-Castro, Shae E. Quirk, Pernille K. Ellegaard, Lesley Berk, and Olivia M. Dean. "Tobacco Use in Bipolar Disorder." Clinical Psychopharmacology and Neuroscience 13, no. 1 (April 30, 2015): 1–11. http://dx.doi.org/10.9758/cpn.2015.13.1.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sinha, Shirshendu, and Ajay Shah. "Pharmacotherapy of Tobacco Use Disorder." American Journal of Psychiatry Residents' Journal 11, no. 9 (September 2016): 8–12. http://dx.doi.org/10.1176/appi.ajp-rj.2016.110903.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, Ashley. "Pharmacotherapy for Treatment of Tobacco Use Disorder." Journal of Psychosocial Nursing and Mental Health Services 61, no. 11 (November 2023): 6–9. http://dx.doi.org/10.3928/02793695-20231011-02.

Full text
Abstract:
Tobacco use disorder (TUD), the leading cause of preventable deaths in the United States, disproportionally impacts those with psychiatric disorders. There are multiple first-line, U.S. Food and Drug Administration–approved pharmacotherapy options for the treatment of TUD. The current review focuses on these medications, underlining practical tips to improve cessation rates, while emphasizing a harm reduction and patient-centered approach to treatment. [ Journal of Psychosocial Nursing and Mental Health Services, 61 (11), 6–9.]
APA, Harvard, Vancouver, ISO, and other styles
8

Benowitz, Neal L., and Evangelia Liakoni. "Tobacco use disorder and cardiovascular health." Addiction 117, no. 4 (October 20, 2021): 1128–38. http://dx.doi.org/10.1111/add.15703.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fernandes, Thiago P., Steven M. Silverstein, Natalia L. Almeida, and Natanael A. Santos. "Visual impairments in tobacco use disorder." Psychiatry Research 271 (January 2019): 60–67. http://dx.doi.org/10.1016/j.psychres.2018.11.024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chawla, Megha, and Kathleen A. Garrison. "Neurobiological Considerations for Tobacco Use Disorder." Current Behavioral Neuroscience Reports 5, no. 4 (October 30, 2018): 238–48. http://dx.doi.org/10.1007/s40473-018-0168-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tobacco Use Disorder"

1

Lee, Sherman. "The effect of acute cigarette smoke exposure on regional pulmonary blood flow, volume, red cell transit and polymorphonuclear leukocyte retention in the rabbit lung." Thesis, University of British Columbia, 1985. http://hdl.handle.net/2429/24840.

Full text
Abstract:
Regional pulmonary blood flow and volume was measured in ten rabbits anesthetized with pentobarbital (30 mg/kg). Tracheostomy was performed and catheters were placed into the jugular vein and carotid artery. The cardiac ⁹⁹mtc output was measured using the indicator-dilution technique using Tc labelled RBC followed by an injection of radiolabelled macroaggregates (MAA) to mark regional blood flow. Measurements were made both before and after either exposure to cigarette smoke (3 cigarettes for ten minutes at 4 puffs/minute) or sham exposure to air. The animals were sacrificed and the lungs were removed with the vessels tied. The lungs were then inflated and rapidly frozen over liquid nitrogen. The lungs were sampled into slices by vertical height, each slice was further sampled and then gamma counted for the injected isotopes. Regional pulmonary blood flow was calculated by setting the total lung MAA counts for each MAA equal to the cardiac output so that the sample flow was calculated as the fraction of sample counts to total counts times the cardiac output. The blood volume was marked by the labelled RBC and RBC transit was calculated as blood volume (ml) divided by blood flow (ml/sec). In a second series of experiments (N=10) , ⁵¹Cr PMN were injected as a bolus along with ⁹⁹mtc RBC in an indicator-dilution run. Following the injection of the cells, the blood flow was marked with MAAs and then the same sham or smoke treatments were given as in the previous experiments. At the end of ten minutes, the animals were sacrificed and the lungs were processed the same as before. Regional PMN retention was calculated as the [formula omitted]. The data show that smoke exposure increased pulmonary blood volume (p<.01), pulmonary transit time (pMedicine, Faculty of
Pathology and Laboratory Medicine, Department of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
2

Cairney, Paul, Donley T. Studlar, and Hadii M. Mamudu. "Global Tobacco Control: Power, Policy, Governance and Transfer." Digital Commons @ East Tennessee State University, 2012. http://a.co/gyOh6d8.

Full text
Abstract:
Political science and tobacco policy--Theories of policy change--The global policy context--European countries and the EU--The UK: a case study--The United States--Other advanced industrial countries--Tobacco control policymaking in developing regions--The WHO Framework Convention on Tobacco Control (FCTC)
https://dc.etsu.edu/etsu_books/1104/thumbnail.jpg
APA, Harvard, Vancouver, ISO, and other styles
3

Yan, Wai-yee Winnie, and 甄惠儀. "The association between prenatal smoke exposure and ADHD in offspring: a review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46943857.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vaid, Isam G. "Self-efficacy to resist smoking as a mediator between nicotine dependence and quit attempt in adolescent smokers in Alabama." Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2008. https://www.mhsl.uab.edu/dt/2009r/vaid.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marcantonio, Ana Carolina Monachini. "Influência do tabagismo nos níveis de beta-defensina 3 no fluido crevicular gengival de indivíduos com periodontite crônica /." Araraquara, 2018. http://hdl.handle.net/11449/153964.

Full text
Abstract:
Orientador: Daniela Leal Zandim Barcelos
Resumo: O propósito deste estudo foi determinar a influência do tabagismo nos níveis de beta-defensina 3 (hBD 3) no fluido crevicular gengival (FCG) de indivíduos com periodontite crônica e avaliar sua relação com saúde e doença periodontal. Além disso, foi investigada a correlação deste peptídeo antimicrobiano com metaloproteinase da matriz (MMP-8) e citocinas pró (IL-10) e anti-inflamatórias (IL-1β, IFN-γ e TNF-α). Um total de 40 indivíduos com periodontite crônica, sendo 20 fumantes (PF) e 20 não fumantes (PNF), e 20 indivíduos sem doença periodontal (S) foram incluídos no estudo. Amostras de FCG de sítios sadios e doentes dos indivíduos com periodontite, e apenas de sítios sadios dos indivíduos periodontalmente saudáveis, foram coletadas com tiras de papel absorvente. A quantificação da hBD 3 foi feita pela técnica ELISA sanduíche e dos marcadores biológicos por ensaio Multiplex. Níveis significativamente menores de hBD 3 foram identificados nos sítios doentes de PF em comparação aos sítios doentes de PNF (p=0,02). Por outro lado, os níveis de hBD 3 nos sítios sadios de PF foram significativamente maiores que nos sítios sadios de PNF e S (p=0,006). Na comparação dos sítios dentro do grupo PF, foi verificado que os sítios doentes apresentavam níveis reduzidos de hBD 3 em comparação com sítios sadios (p=0,04). Já no grupo PNF, os níveis de hBD 3 foram mais elevados nos sítios doentes que nos sítios sadios (p=0,02). Uma correlação negativa foi observada entre os níveis de hBD 3 e MM... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: The purpose of this study was to determine the influence of smoking on gingival crevicular fluid (GCF) levels of beta-defensin 3 (hBD 3) in individuals with chronic periodontitis and to evaluate its relationship with health and periodontal disease. In addition, the correlation of this antimicrobial peptide with matrix metalloproteinase (MMP-8) and pro (IL-10) and anti-inflammatory cytokines (IL-1β, IFN-γ and TNF-α) was investigated. A total of 40 individuals with chronic periodontitis, including 20 smokers (PS) and 20 non-smokers (PNS), and 20 subjects without periodontal disease (H) were included in the study. GCF samples from healthy and diseased sites of individuals with periodontitis, and only from healthy sites of periodontally healthy individuals, were collected with absorbent paper strips. Quantification of hBD 3 was performed by a sandwich ELISA assay and the biological markers levels were analyzed by a multiplex assay. Significantly lower levels of hBD 3 were identified in diseased sites of PS compared to diseased sites of PNS (p = 0.02). On the other hand, the levels of hBD 3 in healthy sites of PS were significantly higher than in healthy sites of PNS and H (p = 0.006). The comparison between the sites within the groups with periodontitis showed reduced levels of hBD 3 in diseased sites of PS compared to healthy sites (p = 0.04), while higher levels of this peptide was detected in diseased sites of PNS compared to healthy sites (p = 0.02). A negative correlation wa... (Complete abstract click electronic access below)
Mestre
APA, Harvard, Vancouver, ISO, and other styles
6

Ursprung, W. W. Sanouri A. "Developing Three New Pathophysiologically Based Measures of Nicotine Dependence: A Dissertation." eScholarship@UMMS, 2014. http://escholarship.umassmed.edu/gsbs_diss/714.

Full text
Abstract:
BACKGROUND: Of the 22 known measures of nicotine dependence (ND), none capture the overall disease severity of physical dependence alone. Instead, they capture constructs related to dependence, such as perceived risk, psychological addiction, smoker motivations, or smoking related behaviors, but none of the measures include only physical withdrawal symptoms to capture physical dependence on nicotine. AIM: To develop a range of nicotine dependence measures that capture physical dependence on nicotine. METHODS: The final measures were developed in a cross-sectional study conducted in three phases: 1) candidate item development through literature review and cognitive interviews, 2) developing and pre-testing the survey, and 3) survey administration and psychometric evaluation to validate three distinct measures. The final survey was conducted at four health clinics and three high schools. Psychometric tests used to select the final measure items included inter-item correlations, sensitivity analyses done by subgroup, item-total correlations, convergent validity tests, and confirmatory factor analysis. The final measures were evaluated using confirmatory factor analysis (CFA), internal reliability, total score distributions, and convergent validity correlations. Relative validity analyses were also conducted using a ratio of F-Statistics to compare the ability of each new measure to differentiate dependent smokers as compared previous measures. RESULTS: The final sample included 275 smokers ranging from 14 to 76 years old (mean=30.9, SD=16.2), who smoked an average of 11.5 cigarettes per day (range=0-50, SD=9.4). The sample was 86.5% white and 57.5% male. The three new measures developed included: 1) the 4-item Withdrawal-Induced Craving Scale (WICS) used to capture severity of craving, the most common physical withdrawal symptom; 2) the 12- item Nicotine Withdrawal Symptom Checklist (NWSC), which measures both overall disease severity and the severity of a comprehensive list of individual physical withdrawal symptoms including withdrawal-induced craving, anger, anxiety, depression, headache, insomnia, loss of focus, restlessness, and stress; and 3) the 6-item brief NWSC (NWSC-b), a short measure which only captures overall disease severity. All of the new measures exhibited a unidimensional factor structure loading highly on a single factor (thought to be physical dependence). They also correlated highly (over 0.6) and significantly (p<0.001) to a battery of convergent validity indices including four widely used nicotine dependence measures: Hooked on Nicotine Checklist (HONC), the Autonomy Over Tobacco Scale (AUTOS), the Fagerström Test for Nicotine Dependence (FTND), and self-rated addiction. CONCLUSION: The WICS, NWSC, and NWSC-b provide three distinct validated tools that can be used by researchers, clinicians, and educators to track the progression of physical dependence on nicotine across a range of smoking behaviors and histories.
APA, Harvard, Vancouver, ISO, and other styles
7

Ngolab, Jennifer. "The Role of VTA Gabaergic Nicotinic Acetylcholine Receptors Containing the α4 Subunit in Nicotine Dependence: A Dissertation." eScholarship@UMMS, 2015. https://escholarship.umassmed.edu/gsbs_diss/851.

Full text
Abstract:
Nicotine dependence is hypothesized to be due to neuroadaptations that ultimately drive compulsive nicotine use. The studies in this thesis aim to understand how the “upregulation” of nicotinic acetylcholine receptors (nAChRs) caused by chronic exposure to nicotine contributes to nicotine reward and nicotine withdrawal. Previous studies have shown that chronic nicotine induces upregulation of nAChRs containing the α4 subunit (α4* nAChR) within the Ventral Tegmental Area (VTA), a brain region critical for the rewarding properties of all illicit drugs. Curiously, α4* nAChR upregulation occurs specifically in the inhibitory GABAergic neuronal subpopulation of the VTA. To determine if increased expression and activation of α4* nAChRs in VTA GABAergic neurons contributes to nicotine dependence behaviors, I devised a viral-mediated, Creregulated gene expression system that selectively expressed α4 nAChR subunits containing a “gain-of-function” point mutation (a leucine mutated to a serine residue at the TM2 9´ position: Leu9´Ser) in VTA GABAergic neurons of adult mice. Sub-reward doses of nicotine were sufficient to activate VTA GABAergic neurons in mice expressing Leu9´Ser α4 nAChR subunits in VTA GABAergic neurons (Gad2VTA: Leu9´Ser mice) and exhibited acute hypolocomotion upon initial injection of low doses of nicotine that developed tolerance with subsequent nicotine exposures compared to control animals. In the conditioned place preference procedure, nicotine was sufficient to condition a significant place preference in Gad2VTA: Leu9´Ser mice at low nicotine doses that failed to condition control animals. I conclude from these data that upregulating α4* nAChRs on VTA GABAergic neurons increases sensitivity to nicotine reward. In a separate study testing the hypothesis that overexpression of Leu9´Ser α4* nAChRs in VTA GABAergic neurons disrupts baseline behavior and promotes anxiety-like behaviors, I found that overexpressing Leu9´Ser α4* nAChRs in VTA GABAergic neurons had a minimal effect on unconditioned anxiety-like behaviors. Drug naïve Gad2VTA: Leu9´Ser and control mice failed to exhibit any behavioral differences in the open-field, marble burying test and elevated plus maze compared to control. Together, these data indicate that overexpression of the “gain-of-function” α4* nAChRs in VTA GABAergic neurons contributes to reward sensitivity without increasing susceptibility to nicotine withdrawal symptoms. My data indicates that nAChRs expressed in VTA GABAergic neurons may be a suitable target for the development of better smoking cessation aids.
APA, Harvard, Vancouver, ISO, and other styles
8

Cury, Laura Lemos. "Habilidades sociais e grau de dependência em pacientes tabagistas internados pela cirurgia vascular em hospital terciário." Faculdade de Medicina de São José do Rio Preto, 2018. http://hdl.handle.net/tede/442.

Full text
Abstract:
Submitted by Suzana Dias (suzana.dias@famerp.br) on 2018-10-31T23:00:32Z No. of bitstreams: 1 LauraCury_dissert.pdf: 453805 bytes, checksum: 7eaccabaffe132f003b0b92e9db63548 (MD5)
Made available in DSpace on 2018-10-31T23:00:32Z (GMT). No. of bitstreams: 1 LauraCury_dissert.pdf: 453805 bytes, checksum: 7eaccabaffe132f003b0b92e9db63548 (MD5) Previous issue date: 2018-03-14
Tobacco is one of the leading causes of premature death in the world and its dependence is maintained by nicotine and determined by biological, behavioral, psychological and sociocultural processes. Intensified consumption makes abstinence symptoms more probable to appear. The social factors that contributed to the experimentation become less motivating and the dependence happens to be controlled by the avoidance of the symptoms of the abstinence. The continued use of the cigarette causes changes in brain physiology that makes its cessation process something continuous and complex. Some triggers identified as abstinence-hindering refer to deficits in social skills. The term HS is used to designate learned behavioral capacities that involves social interactions. The present study was conducted from February to March 2017 and evaluated and correlated degree of nicotine dependence and social skills in sixty smokers patients hospitalized by vascular surgery team at a general hospital in the interior of the State of São Paulo, with the purpose of suggesting a therapeutic group where the deficits in social skills found in this study will be able to be work on. A descriptive type of search was performed. Participants were approached and invited to participate in the research whose data were analyzed quantitatively. Of the 60 participants, 23 were women and 37 were men, mean age was 62.85 years, with 52.51 years using cigarette. Only 18.33% tried to stop smoking and the beginning of use for them were at 10.33 years. Only 21.66% of the dependents did not have a smoker's family member, and 5% reported that their support group were non-smoker. According to the Fagerström test for nicotine, the majority of the evaluated patients have low and medium degree of dependence (adding up the two values). For social skills, the total scores for both genders correlate with the Fagerström test, which shows that the more dependent the more socially skilled, which may mean that the tobacco user feels socially skillful without being, if it is so, largely from a social skills training as part of the smoking cessation treatment.
O tabaco é uma das principais causas de morte prematura no mundo e sua dependência é mantida pela nicotina e determinada por processos biológicos, comportamentais, psicológicos e socioculturais. O consumo intensificado torna possível o surgimento dos sintomas de abstinência. Os fatores sociais que contribuíram para a experimentação passam a ser menos motivadores e a dependência passa a ser controlada pela evitação dos sintomas da abstinência. O uso contínuo do cigarro causa alterações na fisiologia cerebral que farão o processo de cessação do mesmo ser contínuo e complexo. Alguns gatilhos identificados como dificultadores da abstinência referem-se a déficits em habilidades sociais. O termo HS é utilizado para designar capacidades comportamentais aprendidas que envolvem interações sociais. O presente trabalho foi realizado de fevereiro à março de 2017 e avaliou e correlacionou grau de dependência de nicotina e habilidades sociais em sessenta pacientes tabagistas internados pela equipe de cirurgia vascular em um hospital geral do interior do Estado de São Paulo com o intuito de sugerir um grupo terapêutico para que os déficits em habilidades sociais encontrados sejam trabalhados posteriormente. Foi realizada uma pesquisa do tipo descritiva. Os participantes foram abordados e convidados a participar da pesquisa cujos dados obtidos foram analisados quantitativamente. Dos 60 participantes, 23 eram mulheres e 37 eram homens, de idade média de 62,85 anos, com 52,51 anos de uso de cigarro. Apenas 18,33% tentaram parar de fumar e o início do uso foi aos 10,33 anos. Apenas 21,66% dos dependentes não possuíam nenhum familiar também tabagista e 5% referiu que o grupo de apoio não era fumante. Segundo o teste Fagerström para Nicotina a maioria dos avaliados encontra-se com grau de dependência baixa e média (somando-se os dois valores). Quanto as habilidades sociais os escores totais para ambos os gêneros correlacionam -se com o teste de Fagerström, o que mostra que quanto mais dependente mais habilidoso socialmente, o que pode significar que o usuário do tabaco se sinta habilidoso socialmente sem o ser, beneficiando-se assim, largamente de um treino de habilidades sociais como parte do tratamento de cessação do tabagismo.
APA, Harvard, Vancouver, ISO, and other styles
9

Mexal, Sharon. "Differential expression in the hippocampus of schizophrenic and control smokers : a high-throughput analysis of the effects of psychopathology, smoking, and postmortem brain parameters on gene expression /." Connect to full text via ProQuest. IP filtered, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Almeida, Adriana Ávila de [UNESP]. "Expressão dos genes CYP1A1, CYP1B1, CYP2A6 e CYP2E1 em fumantes com câncer bucal." Universidade Estadual Paulista (UNESP), 2018. http://hdl.handle.net/11449/153357.

Full text
Abstract:
Submitted by Adriana Ávila de Almeida null (celdrica2003@yahoo.com.br) on 2018-03-23T16:45:45Z No. of bitstreams: 1 Tese Final - Adriana Ávila de Almeida.pdf: 2506211 bytes, checksum: e38a3f026d55d541be0fd2ec9142a2a2 (MD5)
Approved for entry into archive by Silvana Alvarez null (silvana@ict.unesp.br) on 2018-04-03T21:06:34Z (GMT) No. of bitstreams: 1 almeida_aa_dr.sjc.pdf: 2506211 bytes, checksum: e38a3f026d55d541be0fd2ec9142a2a2 (MD5)
Made available in DSpace on 2018-04-03T21:06:34Z (GMT). No. of bitstreams: 1 almeida_aa_dr.sjc.pdf: 2506211 bytes, checksum: e38a3f026d55d541be0fd2ec9142a2a2 (MD5) Previous issue date: 2018-02-05
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Os carcinógenos do tabaco estão relacionados a diversos tipos de câncer incluindo o carcinoma de células escamosas (CCE) bucal. Aliado ao álcool, o tabaco contribui para o desfecho desfavorável destes casos. A susceptibilidade individual ao câncer pode estar relacionada a expressão das enzimas que metabolizam tais carcinógenos. O objetivo deste trabalho é avaliar a expressão dos genes CYP1A1, CYP1B1, CYP2A6 e CYP2E1 no CCE bucal por meio de qPCR. Foram coletadas amostras de 32 indivíduos com CCE e de 15 controles submetidos a cirurgias bucais por lesões benignas. Foram constituídos quatro grupos: Grupo CCE fumante (n=26), Grupo CCE não fumante (n=6), Grupo controle fumante (n=9) e Grupo controle não fumante (n=6). O Teste de Fagerström para Dependência a Cigarros (TFDC) foi usado para avaliar a dependência nicotínica (DN) e AUDIT para avaliação do consumo de etílicos. Houve diminuição da expressão do gene CYP1B1 nos casos de CCE comparados aos controles. Foram encontradas diferenças estaticamente significativas de expressão gênica de CYP1B1 entre os Grupos CCE fumante e controle fumante (p=0,0018), Grupo CCE não fumante e controle não fumante (p=0,0079) e CCE fumante com CCE não fumante (p=0,0385) e entre os quatro grupos (p<0,0001). Houve diminuição da expressão do CYP2A6 no Grupo CCE fumante em relação ao Grupo controle, mas apenas um paciente do Grupo controle expressou este gene. Houve aumento da expressão de CYP2E1 entre os Grupos CCE fumante e controle fumante (p=0,0424). Concluindo, foi encontrada grande variabilidade interindividual no estudo da expressão dos genes estudados. Houve maior expressão de CYP1A1 e CYP2E1 em amostras de indivíduos fumantes com CCE. Os genes CYP1B1 e CYP2A6 estavam menos expressos no Grupo CCE fumante em relação ao Grupo controle. Para os genes CYP1B1 e CYP2E1 foram encontrados valores significativos na correlação entre a expressão gênica e parâmetros demográficos e de perfil tabágico no Grupo controle fumante, e do AUDIT no Grupo CCE não fumante. O gene CYP2E1, além de estar relacionado ao metabolismo do álcool, também deve ser considerado importante marcador do metabolismo dos carcinógenos derivados do tabaco.
Tobacco carcinogens are related to various types of cancer, including oral squamous cell carcinoma (OSCC). Allied to alcohol, tobacco contributes to the unfavorable outcome of the cases. Individual cancer susceptibility may be related to an expression of the enzymes that metabolize such carcinogens. The aim of this work is to evaluate the expression of the genes CYP1A1, CYP1B1, CYP2A6 and CYP2E1 on OSCC by qPCR. Samples were collected from 32 individuals with OSCC and 15 controls submitted to oral surgeries due to benign lesions. There were four groups: Smoker SCC group (n = 26), nonsmoker SCC group (n = 6), Smoker control group (n = 9) and nonsmoker control group (n = 6). The Fagerström Test for Cigarette Dependence (TFCD) was used to evaluate nicotinic dependence (ND) and AUDIT for the evaluation of alcohol consumption. There was a decrease in CYP1B1 gene expression in cases of SCC compared to controls. (P = 0.0018); smoker CCE and non-smoker control (p = 0.0079); smoker SCC with nonsmoker SCC (p = 0.0385) and between the four groups (p <0.0001). There was a decreased expression in CYP2A6 in the smoker SCC Group compared to the control group, but only one control group patient expressed this gene. There was an increased expression of CYP2E1 between the smoking and nonsmoking SCC groups (p = 0.0424). In conclusion, large interindividual variability was found in the study of the expression of the genes studied. There was greater expression of CYP1A1 and CYP2E1 in samples from smokers with SCC. The CYP1B1 and CYP2A6 genes were less expressed in the smoker SCC Group. Significant values were found for the CYP1B1 and CYP2E1 genes in the correlation between a gene expression and a parameter and a non-smoker control group, non-smoker control group and AUDIT. The CYP2E1 gene, besides being related to alcohol metabolism, should also be considered an important marker of the metabolism of the carcinogens derived from tobacco.
2016/08633-0
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tobacco Use Disorder"

1

M, Ranney Leah, United States. Agency for Healthcare Research and Quality., and RTI International-University of North Carolina Evidence-based Practice Center., eds. Tobacco use: Prevention, cessation, and control. Rockville, MD: U.S. Dept. of Health and Human Services, Agency for Healthcare Research and Quality, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

United States. Department of Health and Human Services, Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health, and Pan American Health Organization, eds. Tabaquismo y salud en las Américas: Informe de la Cirujana General, 1992, en colaboración con la Organización Panamericana de la Salud. [Atlanta, Ga.?]: Departamento de Salud y Servicios Sociales de los Estados Unidos de America, Servicio de Salud Pública, Centros para el Control de Enfermedades, Centro Nacional para la Prevención de Enfermedades Crónicas y Promoción de la Salud, Oficina de Tabaquismo y Salud, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1947-, Warner Kenneth E., and Robert Wood Johnson Foundation, eds. Tobacco control policy. San Francisco: Jossey-Bass, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tracy, Orleans C., and Slade John 1949-, eds. Nicotine addiction: Principles and management. New York: Oxford University Press, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Foundation), Symposium on Understanding Nicotine and Tobacco Addiction (2005 Novartis. Understanding nicotine and tobacco addiction. Chichester, UK: John Wiley & Sons, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mackay, Judith. The tobacco atlas. [Geneva]: World Health Organization, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Services, U. S. Department of Health and Human. Tobacco use among U.S. racial/ethnic minority groups. [Atlanta, Ga.]: Dept. of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

U.S. Department of Health and Human Services. Tobacco use among U.S. racial/ethnic minority groups. [Atlanta, Ga.]: Dept. of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

G, Robinson Robert, and Centers for Disease Control and Prevention (U.S.), eds. Pathways to freedom: Winning the fight against tobacco. [Atlanta, Ga.]: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

National Cancer Policy Board (U.S.), ed. Taking action to reduce tobacco use. Washington, DC: National Academy Press, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tobacco Use Disorder"

1

Freudenreich, Oliver. "Tobacco Use Disorder." In Psychotic Disorders, 359–74. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-29450-2_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

MacKillop, James, Joshua C. Gray, Max M. Owens, Jennifer Laude, and Sean David. "Tobacco Use Disorder." In Integrating Psychological and Pharmacological Treatments for Addictive Disorders, 99–123. New York, NY : Routledge, 2017. |: Routledge, 2017. http://dx.doi.org/10.4324/9781315683331-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Drobes, David J. "Pharmacological treatment of tobacco use disorder." In APA handbook of psychopharmacology., 609–29. Washington: American Psychological Association, 2019. http://dx.doi.org/10.1037/0000133-027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Carrillo, Noel. "Nicotine Dependence and Tobacco Use Disorder Treatment." In Psychiatry Update, 101–11. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-86430-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Runyan, Christine, and James Anderson. "Tobacco use disorder in primary care mental health." In Companion to Primary Care Mental Health, 457–69. London: CRC Press, 2022. http://dx.doi.org/10.1201/9781846198465-34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mohamed, Mohamad Haniki Nik, and Ahmed Ibrahim Fathelrahman. "Medical Devices for Management of Tobacco Use Disorder." In Medical Devices for Pharmacy and Other Healthcare Professions, 21–38. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003002345-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kalgotra, Pankush, Ramesh Sharda, Bhargav Molaka, and Samsheel Kathuri. "Time-Based Comorbidity in Patients Diagnosed with Tobacco Use Disorder." In Studies in Big Data, 401–13. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-53817-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Blanco, Adriana, Vera da Costa e. Silva, and Maristela Monteiro. "Tobacco Use: Prevention." In Substance Abuse Disorders, 233–49. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9780470975084.ch20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Crome, Ilana B., and Marcus R. Munafò. "Epidemiology of Tobacco Use." In Substance Abuse Disorders, 205–32. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9780470975084.ch19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Xin, Yu. "Comments Regarding Epidemiology of Tobacco Use, Tobacco Use: Prevention and Tobacco Abuse: Treatment and Management." In Substance Abuse Disorders, 293–95. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9780470975084.ch27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tobacco Use Disorder"

1

El Hajj, Maguy, Ahmed Awaisu, Nadir Kheir, Mohamad Haniki, Rula Shami, Rana Saleh, Noora AlHamad, Ahmad Almulla, and Ziyad Mahfoud. "Evaluation of an Intensive Education Program on the Treatment of Tobacco-use Disorder for Pharmacists: A Randomized Controlled Trial." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0112.

Full text
Abstract:
Tobacco use is one of the main causes of premature deaths and preventable diseases in Qatar. The aim of this randomized controlled trial (RCT) is to design, implement, and evaluate an intensive education program on tobacco-use treatment for pharmacists in Qatar. The study objectives are to assess the effectiveness of the program on pharmacists’ knowledge, skills, attitudes and perceived self-efficacy toward tobacco cessation. Methods: Community pharmacists practicing in Qatar were eligible for participation in the study. Consenting participants were randomly allocated to intervention or control groups. Participants in the intervention group received an intensive education program on treatment of tobacco-use disorder. A short didactic session on a non-tobacco-related topic was delivered to pharmacists in the control group. Outcomes were assessed using survey instruments. Results: Participants in the intervention group (n=57) achieved significantly higher total tobacco-related knowledge scores (mean=33 points) than those in the control group (n=37) (mean=24.5 points) with a p-value of <0.001. Post-intervention total knowledge scores were significantly higher than the baseline scores for participants who received intensive tobacco education with a mean difference of 6.6 points (p-value <0.001). Overall attitudes toward tobacco cessation and self-efficacy in tobacco cessation interventions were better in the group of pharmacists who received tobacco education compared to those who did not. For instance, 43.4% of pharmacists in the intervention group “strongly agreed” that their counseling will increase a patient’s likelihood of quitting tobacco use compared to 14.7% in the control group (p-value=0.014). Furthermore, 20.4% of pharmacists in the intervention group reported that they are “extremely confident” to use appropriate questions to ask patients when providing tobacco cessation counseling versus 5.9% in the control group (p-value=0.005). Conclusion: The findings of this study suggest that provision of an intensive educational program on the treatment of tobacco use disorders results in improved tobacco-related knowledge and self-efficacy in tobacco cessation interventions.
APA, Harvard, Vancouver, ISO, and other styles
2

El Hajj, Maguy, Ahmed Awaisu, Nadir Kheir, Mohamad Haniki, Rula Shami, Rana Saleh, Noora AlHamad, Ahmed Almulla, and Ziyad Mahfoud. "Assessment of an Intensive Education Program on the Treatment of Tobacco-Use Disorder for Pharmacists using OSCE (Objective Structured Clinical Examination)." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0113.

Full text
Abstract:
Tobacco use is one of the main causes of morbidity and mortality in Qatar. The aim of this randomized controlled trial (RCT) is to design, implement, and evaluate an intensive education program on tobacco-use treatment for pharmacists in Qatar. The study objectives are to assess the effectiveness of the program on pharmacists’ skills toward tobacco cessation. Methods: A random sample of community pharmacists in Qatar was selected for participation. Consenting participants were randomly allocated to intervention or control groups. Participants in the intervention group received an intensive education program on treatment of tobacco-use disorder. A short didactic session on a non-tobacco-related topic was delivered to pharmacists in the control group. The pharmacists’ tobacco cessation skills were assessed using an Objective Structured Clinical Examination (OSCE). Six-station OSCE targeting core smoking cessation competencies and skills was completed by participants in both groups. Performance of participants was assessed using validated assessment checklists that comprised analytical and global assessment sections. Results: A total of 54 and 32 participants in the intervention and the control group respectively completed the OSCE. Overall, pharmacists in the intervention group performed better in the analytical and global assessment sections than those in the control group. For example, for case 1, mean scores for developing rapport, data gathering and management were 2.76 vs 0.97 (p-<0.001), 5 vs 2.81 (p <0.001), and 3.5 vs 2.25 (p=0.001) respectively for the intervention group compared to the control group. Mean total analytical scores were 12.06 vs 6.4 (p-<0.001) for intervention compared to the control group for case 1. Furthermore, mean global assessment scores for case 1 were 3.19 vs 2.41 (p=0.009) for the intervention compared to the control group. Conclusion: The study results suggest that provision of an intensive educational program on the treatment of tobacco use results in improved skills toward tobacco cessation.
APA, Harvard, Vancouver, ISO, and other styles
3

Lathan, Christopher S., and Rebecca K. Jackson. "Abstract A003: Group tobacco education at short- and long-term substance use disorder programs." In Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 2-5, 2018; New Orleans, LA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp18-a003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fitzke, Reagan, Jordan Davis, and Eric Pedersen. "Co-use of Tobacco/Nicotine and Cannabis Among Veterans: A Preliminary Investigation of Prevalence and Associations with Mental Health Outcomes." In 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.10.

Full text
Abstract:
While tobacco and cannabis use rates remain high in the general U.S. population, veterans from the conflicts in Iraq and Afghanistan (i.e., OEF/OIF veterans) are at particularly high risk of high rates of cannabis and tobacco use. Co-use of tobacco/nicotine and cannabis (i.e., using both substances within a specified period of time or combining the drugs within the same device for use) is of growing prevalence in the United States. Tobacco/nicotine and cannabis use is often associated with poor mental health outcomes such as stress, anxiety, and depression. However, little is understood about the prevalence rates of tobacco/nicotine and cannabis co-use among U.S. veterans as well as associations with mental health symptomology. The current study aimed to investigate types of tobacco/nicotine and cannabis co-use among veterans, as well as associations between co-use and mental health outcomes of stress, depression, anxiety, and posttraumatic stress disorder. Participants (N= 1,548) were recruited through social media websites and completed an online survey as part of a larger study. The majority (80%) endorsed tobacco/nicotine and/or cannabis use in the past 30 days. Descriptive analyses were run to assess prevalence of use within the sample. Mean comparisons were conducted to assess differences in past 30-day frequency of use and for mental health outcomes between co-users and single users of either substance. Among the larger sample, 90% endorsed lifetime use of tobacco/nicotine, 23% endorsed lifetime use of cannabis, and 21% endorsed any lifetime co-use of both substances. These participants also endorsed past 30 day use of tobacco/nicotine (77%), cannabis (10%), and co-use (7%). Among the past 30-day cannabis users, 66% reported also using tobacco/nicotine, while 9% of past 30-day tobacco/nicotine users also reported cannabis use. When comparing cannabis-only users to co-users of cannabis and tobacco/nicotine, anxiety symptoms were reported as significantly higher among co-users. Tobacco/nicotine-only users endorsed higher past 30-day frequency of cigarettes and e-cigarettes compared to co-users; however, co-users endorsed significantly higher levels of stress and symptoms of PTSD, depression, and anxiety compared to tobacco/nicotine-only users. Results suggest that the addition of cannabis use in conjunction with tobacco/nicotine use may be associated with greater mental health symptoms among veterans. Findings have implications for future veteran mental health care and substance use treatment among tobacco/nicotine and cannabis co-users.
APA, Harvard, Vancouver, ISO, and other styles
5

Reese, Z., J. Deepak, H. Gogineni, and C. Clancy. "Smoke and Mirrors: Evaluation of Tobacco Use Disorder Education in a Pulmonary and Critical Care Fellowship." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3967.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wyatt, Riley, Amy Cohn, and Sarah Ehlke. "Exploring sensation-seeking and first cannabis use experiences as correlates of current cannabis use problems in young adult cannabis and tobacco co-users." In 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.48.

Full text
Abstract:
Introduction: Current cannabis use is high in young adults (ages 18-24) and cannabis use disorder (CUD) rates have increased over the last decade. Subjective responses to one’s first use of cannabis may explain continued use, wherein more positive first use experiences influence progression to regular and problematic use. Sensation seeking is associated with cannabis use and may also influence cannabis problem severity. This study examined the relationship between subjective experiences at first cannabis use and sensation seeking on cannabis use behavior and CUD diagnosis. Method: Participants were 97 young adult current cannabis and tobacco co- users (55.7% male, 50.5% White) who completed the baseline survey of a longitudinal study examining daily patterns of tobacco and cannabis use and co-use. Participants completed the 4-item Brief Sensation Seeking Scale and indicated intensity of 15 sensations at first cannabis use (1 = not at all to 5 = intense): dizziness, lightheadedness, nausea, paranoia, confusion, happiness, anxiety, taste, smell, relaxation, energy, difficulty inhaling, coughing or choking, giddiness or laughter, and rush or “buzz.” Cannabis use outcomes included: (1) past 30-day number of days used cannabis; (2) past 30-day cannabis intoxication intensity (1 = not at all high to 10 = extremely high); and (3) likelihood of a CUD (score ≥ 12 on the Cannabis Use Disorder Identification Test- Revised). Analyses: A principal components analysis (PCA) reduced the 15 sensations into factors. Next, separate regression analyses (linear or binary logistic) were conducted to examine the associations of the PCA-derived factors and sensation seeking on the cannabis outcomes, controlling for gender, race, and age at first cannabis use. Results: Over half (61.9%) of the participants met criteria for a CUD. PCA results indicated a 4-factor solution: (1) “positive emotional experiences” (e.g., happy); (2) “negative physical experiences” (e.g., dizzy); (3) “negative emotional experiences” (e.g., paranoia); and (4) “taste and smell.” Regression results indicated greater negative physical experiences were associated with an increased likelihood of a CUD diagnosis (AOR = 1.93, p = .038) and lower average cannabis intoxication (b = -0.343, p = .049). Greater negative emotional experiences at first use were associated with less frequent cannabis use in the past 30 days (b = -2.043, p = .028). Conclusion: Negative emotional experiences associated with first use of cannabis may impede continued use. Negative physical experiences (e.g. nausea, lightheadedness) may be variable in perception, which could explain the inconsistent associations of this factor with CUD diagnosis and past 30-day use. Understanding subjective experiences of first cannabis use could be used as a treatment target by helping patients identify reinforcing sensations associated with their use, and guiding them to sober activities with similar sensations.
APA, Harvard, Vancouver, ISO, and other styles
7

Hoidrag, Traian. "Partnership between educational institution, family and community for the recovery of adolescents with addictive behaviors." In Condiții pedagogice de optimizare a învățării în post criză pandemică prin prisma dezvoltării gândirii științifice. "Ion Creanga" State Pedagogical University, 2021. http://dx.doi.org/10.46728/c.18-06-2021.p235-242.

Full text
Abstract:
Consumption of psychoactive substances and other addictive behaviors is a risk factor that can disrupt the good somatic, psychological, social and educational development of adolescents. The fact that many adolescents consume tobacco, alcohol, cannabis or other substances, and a significant number of them end up being diagnosed with substance use disorder and other associated disorders, requires multiple human, financial and material resources and special attention from specialists. involved in reducing the demand and supply of drugs. Addiction treatment is a complex issue, requiring a multidisciplinary approach and long-term co-optation of representatives of educational institutions, adolescents and members of local communities in which various prevention or medical, psychological or social assistance programs are carried out. Cooperation is very important for the efficient use of resources available to each party involved in the process of recovering those affected by addictive behaviors, raising awareness of the risks of continued substance use, reducing stigma, conducting interventions to meet the needs of beneficiaries, families them and the members of the community in which they live, the diversification of support services, the provision of continuous psychosocial support and the reintegration of adolescents into the family, social and educational environment.
APA, Harvard, Vancouver, ISO, and other styles
8

"EPIDEMIOLOGICAL CHARACTERISTICS OF A SAMPLE OF PATIENTS WITH SUBSTANCE USE FROM THE PSYCHIATRIC CARE UNIT OF THE SOCIAL AFFAIRS SERVICE OF THE UNIVERSITY OF SALAMANCA." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p019v.

Full text
Abstract:
Introduction: University life presents changes and challenges that may affect the mental health of its community and be the onset of substance use. Aim: To study epidemiological characteristics in our sample to help to improve prevention and treatment for mental health problems related to substance use. Materials and Methods: The descriptive study is based on a sample of 49 people, 37 women and 12 men, members of the university community. A database was designed with clinical information about psychiatric patients obtained from the interview and entry sheets during the first visit. Results: 53,1% of the sample confirmed substance use. The mean age of patients was 22,35 years and 69,2% of them were women and 30,8% were men. Alcohol was the main used substance (80,8%), followed by tobacco (57,7%) and cannabis (30,8%). Most patients were from other provinces of Spain different from Salamanca (57,7%). Law and Social Sciences (38,5%) and Health Sciences (26,9%) were the most frequent academic fields. The main contact method was self-consultation (76,9%) and in most cases (46,2%) the reason of the consultation was not specific. After the interview, the main diagnosis impressions were major depressive disorder (19,2%), anxiety disorder (15,3%) and prodromal symptoms of psychosis (15,4%). Most of the patients were treated with a combination of medication and psychotherapy (42,3%). Conclusion: We should consider the possible impact of substance use in our patient’s mental health and take account of it when choosing their treatment. We should continue studying epidemiological characteristics to help to improve prevention measures and treatments in the future.
APA, Harvard, Vancouver, ISO, and other styles
9

Denson, Rebecca, and Robin Mermelstein. "Ecological Momentary Assessment of Cannabis Use Contexts." In 2022 Annual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.02.000.28.

Full text
Abstract:
BACKGROUND: As recreational cannabis use increases, it is important to document the context in which use occurs. Cannabis use contexts may relate to safety and daily functioning (e.g., if cannabis is used while driving or at work/school) as well as motives for use (e.g., if cannabis is used in social environments). The present study used ecological momentary assessment (EMA) to examine the context surrounding cannabis use in adults’ natural environments. METHODS: Participants were recruited for a longitudinal study of dual use of cigarette and e-cigarettes. Data were collected in Illinois prior to legalization of recreational cannabis use. Participants completed baseline questionnaires and two seven-day waves of EMA; the current study included those who reported cannabis use on EMA interviews. Participants completed EMA when randomly prompted (5-6 times/day) and when using tobacco products. EMA reports measured past-hour substance use and current location, behavior, and social environment. Descriptive analyses evaluated relative frequencies of EMA events when cannabis use was reported (cannabis use events) and not reported (non-use events). Cannabis use and non-use event frequencies were examined by social environment (alone; with a partner/spouse, family, friends, children, coworkers, other), location (home, school/work, coffee shop/restaurant, sport/entertainment venue, car, other transit, bar/club), and behavior (hanging out, socializing, transit/driving, relaxing, texting/talking on phone, using a computer/app, nothing, other). Participants chose one location and could select all items that applied for social environment and behavior. Event frequencies were also examined by day of the week and time of day (4:00-8:59 AM, 9:00 AM-1:59 PM, 2:00-5:59 PM, 6:00-9:59 PM, and 10:00 PM-3:50 AM). RESULTS: Data come from 200 participants (35.5% female; mean age = 30; 11.5% Hispanic/Latino; 44.5% Non-Hispanic White; 29.5% Non-Hispanic Black; 10.0% Asian/Pacific Islander; 4.5% other race/ethnicity). Past 6-month cannabis use frequency was reported at baseline: 12.5% no use, 10.5% monthly or less, 14% 2-4 times/month, 15% 2-3 times/week, 48% 4+ times/week. The average baseline score on the Cannabis Use Disorders Identification Test-Revised was 9.90 (SD = 6.57). Overall, 14,160 EMA events were captured with 2,672 cannabis use events and 11,488 non-use events. Most cannabis use (77.2%) occurred at home. 9.1% of cannabis use occurred when driving/in transit. At cannabis use times, participants reported hanging out (41.5%), relaxing (35.0%), watching TV/movies (29.2%), and socializing (24.4%). Participants were alone in 41.0% of cannabis use events; when not alone during cannabis use, participants were most often with friends (48.0% of social cannabis use events), a partner/spouse (43.1%), or a family member (24.1%). Cannabis use was relatively consistent across days of the week, with slight increases on Thursday (15.9%) and Friday (16.4%). Most cannabis use (34.5%) occurred between 6:00-9:59 PM. CONCLUSIONS: These findings characterize the naturalistic context of cannabis use among a community sample of adults. Most cannabis use occurred at home and when engaging in leisure activities (e.g., relaxing, hanging out). Cannabis use did not appear to be very common in hazardous situations (e.g., while driving). As cannabis use continues to increase, the naturalistic context of cannabis use has implications for safety, motives, and cannabis use disorder.
APA, Harvard, Vancouver, ISO, and other styles
10

Berey, Benjamin, Elizabeth Aston, Ricarda Pritschmann, Cara Murphy, and Ali Yurasek. "Initial validation of a brief assessment of cannabis demand among young adult college students." In 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.12.

Full text
Abstract:
Behavioral economic models of addiction posit that cannabis’s reinforcing value (demand) is linked to use. The Marijuana Purchase Task (MPT; Aston et al., 2015) quantifies demand by assessing hypothetical cannabis consumption across escalating price points. Indices generated from MPT performance include intensity (i.e., amount consumed when free), Omax (i.e., peak expenditure), Pmax (i.e., price at peak expenditure), elasticity (i.e., degree that consumption decreases as price increases), and breakpoint (i.e., cost suppressing consumption to zero). Cannabis demand is linked to engagement in risky behaviors and cannabis use disorder (CUD) symptomology. However, the length of the MPT makes repeated assessment of state-dependent changes in cannabis demand difficult, which limits clinical utility. Brief assessments of alcohol and cigarette demand exist that measure intensity, Omax, and breakpoint. Thus, the aim of the current study was to develop and validate a brief assessment of cannabis demand. College students (N=211, Mage=19.91, SD=1.44; 63% Female; 56.4% Non-Hispanic Caucasian) who reported past-month cannabis use ≥3 times completed an online survey. Participants completed the MPT, a 3-item brief assessment of marijuana demand (BAMD) assessing intensity, Omax, and breakpoint, and measures of demographics, cannabis use frequency, cannabis-related negative consequences, CUD symptomology based on DSM-5 criteria, and cannabis craving. Convergent validity was examined via bivariate correlations of demand indices on the BAMD, MPT, and cannabis outcome measures. Divergent validity was assessed via independent samples t-tests to examine whether demand indices on the BAMD differed based on the presentation or absence of CUD. A one-way between-subjects ANOVA with planned comparisons was tested to compare effects of CUD severity (mild/moderate/severe) on BAMD demand indices. Intensity, Omax, and breakpoint were significantly correlated across the MPT and BAMD (rs=.30 – .79, ps<.01). Intensity, Omax, and breakpoint on the MPT and BAMD were significantly correlated with current cannabis craving, CUD severity, and cannabis-related negative consequences (rs=.18 – .48, ps<.05). Only intensity and Omax were significantly correlated with cannabis use (rs=.16 – .43, ps<.01). Individuals with (versus without) a CUD reported significantly greater intensity and Omax (ps< .01), but not breakpoint, on the MPT and BAMD. There were significant effects of CUD severity on B-MPT demand indices (ps<.05). Planned comparisons revealed that individuals with a moderate or severe CUD had significantly elevated intensity, Omax, and breakpoint on the BAMD compared to individuals with a mild CUD. Only breakpoint differentiated individuals with a moderate and severe CUD. This is the first study to validate a brief assessment of cannabis demand. Consistent with prior alcohol and tobacco research, the BAMD espoused convergent validity with the MPT and divergent validity by differentiating individuals with and without a CUD and along the CUD severity continuum. Thus, the BAMD may be a useful tool to assess links between specific indices of cannabis demand and clinically-relevant outcomes over time and in real-world settings. However, given the rise in novel cannabis products with different modes of administration and varying potencies, future research should examine whether demand differs based on these factors. Further, replicating these findings among more diverse populations is essential.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tobacco Use Disorder"

1

White, D. J. Musculoskeletal Disorders Related to Cigarette Smoking and Tobacco Use. Fort Belvoir, VA: Defense Technical Information Center, May 1996. http://dx.doi.org/10.21236/ada309218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Heyns,, Christof, Rachel Jewkes,, Sandra Liebenberg,, and Christopher Mbazira,. The Hidden Crisis: Mental Health on Times of Covid-19. Academy of Science of South Africa (ASSAf), 2021. http://dx.doi.org/10.17159/assaf.2019/0066.

Full text
Abstract:
[This Report links with the video "The policy & practice of drug, alcohol & tobacco use during Covid-19" http://hdl.handle.net/20.500.11911/171 ]. The COVID-19 pandemic is most notably a physical health crisis, but it strongly affects mental health as well. Social isolation, job and financial losses, uncertainty about the real impact of the crisis, and fear for physical well-being affect the mental health of many people worldwide. These stressors can increase emotional distress and lead to depression and anxiety disorders. At the same time, there are enormous challenges on the health care side. People in need of mental health support have been increasingly confronted with limitations and interruptions of mental health services in many countries. In May 2020, the United Nations already warned that the COVID-19 pandemic has the seeds of a major mental health crisis if action is not taken. The panel discussed and analysed mental health in times of the COVID-19 pandemic with reference to South Africa, Nigeria, Germany and Spain.
APA, Harvard, Vancouver, ISO, and other styles
3

Gender-specific pathways mediate the risk of substance use in adolescents with ADHD. ACAMH, December 2019. http://dx.doi.org/10.13056/acamh.10679.

Full text
Abstract:
Data suggest that children with attention-deficit/hyperactivity disorder (ADHD) are more likely to start smoking tobacco and/or marijuana earlier in childhood than unaffected children, and then escalate use during adolescence. Now, a study by researchers at the University of Minnesota has examined the mediating pathways underlying this association between childhood ADHD and later substance-abuse problems.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tobacco Use Disorder' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography